Andy Mercer
Mercer, Andrew A.
Mercer, A. A. (Andrew A.)
Mercer, A. A.
VIAF ID: 75032408 (Personal)
Permalink: http://viaf.org/viaf/75032408
Preferred Forms
- 100 0 _ ‡a Andy Mercer
- 200 _ | ‡a Mercer ‡b Andrew A.
- 100 1 _ ‡a Mercer, A. A.
- 100 1 _ ‡a Mercer, A. A. ‡q (Andrew A.)
-
- 100 1 _ ‡a Mercer, Andrew A.
- 100 1 _ ‡a Mercer, Andrew A.
4xx's: Alternate Name Forms (9)
Works
Title | Sources |
---|---|
Analysis of an orf virus chemokine-binding protein: Shifting ligand specificities among a family of poxvirus viroceptors | |
Ankyrin Repeat Proteins of Orf Virus Influence the Cellular Hypoxia Response Pathway | |
Bovine papular stomatitis virus encodes a functionally distinct VEGF that binds both VEGFR-1 and VEGFR-2. | |
Characterization of immunostimulatory components of orf virus (parapoxvirus ovis). | |
Comparative analysis of genome sequences of three isolates of Orf virus reveals unexpected sequence variation | |
Conservation and variation of the parapoxvirus GM-CSF-inhibitory factor (GIF) proteins. | |
Deletion of the Chemokine Binding Protein Gene from the Parapoxvirus Orf Virus Reduces Virulence and Pathogenesis in Sheep | |
Development of orf virus as a bifunctional recombinant vaccine: surface display of Echinococcus granulosus antigen EG95 by fusion to membrane structural proteins | |
Effect of a broad-specificity chemokine-binding protein on brain leukocyte infiltration and infarct development. | |
The establishment of a genetic map of orf virus reveals a pattern of genomic organization that is highly conserved among divergent poxviruses. | |
The genome of pseudocowpoxvirus: comparison of a reindeer isolate and a reference strain | |
How viruses affect the cell cycle through manipulation of the APC/C. | |
Identification and characterization of an orf virus homologue of the vaccinia virus gene encoding the major envelope antigen p37K. | |
The immune and inflammatory response to orf virus. | |
In vivo recognition of orf virus early transcriptional promoters in a vaccinia virus recombinant | |
Inactivated parapoxvirus ovis (Orf virus) has antiviral activity against hepatitis B virus and herpes simplex virus | |
Induction of bacteremia in newborn rats by Escherichia coli K1 is correlated with only certain O (lipopolysaccharide) antigen types. | |
Infection with recombinant orf viruses demonstrates that the viral interleukin-10 is a virulence factor | |
Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3 | |
Lipopolysaccharide, capsule, and fimbriae as virulence factors among O1, O7, O16, O18, or O75 and K1, K5, or K100 Escherichia coli. | |
Molecular genetic analysis of orf virus: a poxvirus that has adapted to skin | |
Orf virus and vaccinia virus do not cross-protect sheep | |
Orf virus cell cycle regulator, PACR, competes with subunit 11 of the anaphase promoting complex for incorporation into the complex | |
The Orf virus E3L homologue is able to complement deletion of the vaccinia virus E3L gene in vitro but not in vivo | |
Orf virus-encoded chemokine-binding protein is a potent inhibitor of inflammatory monocyte recruitment in a mouse skin model | |
Orf virus-encoded interleukin-10 inhibits maturation, antigen presentation and migration of murine dendritic cells | |
Orf virus encodes a novel secreted protein inhibitor of granulocyte-macrophage colony-stimulating factor and interleukin-2. | |
Orf virus IL-10 reduces monocyte, dendritic cell and mast cell recruitment to inflamed skin | |
The orf virus inhibitor of apoptosis functions in a Bcl-2-like manner, binding and neutralizing a set of BH3-only proteins and active Bax. | |
Orf virus inhibits interferon stimulated gene expression and modulates the JAK/STAT signalling pathway | |
Orf virus interleukin-10 inhibits cytokine synthesis in activated human THP-1 monocytes, but only partially impairs their proliferation | |
The orf virus OV20.0L gene product is involved in interferon resistance and inhibits an interferon-inducible, double-stranded RNA-dependent kinase | |
Orf virus VEGF-E NZ2 promotes paracellular NRP-1/VEGFR-2 coreceptor assembly via the peptide RPPR. | |
ORFV: a novel oncolytic and immune stimulating parapoxvirus therapeutic. | |
Ovine diseases. Orf. | |
Parapoxvirus of red deer: evidence for its inclusion as a new member in the genus parapoxvirus. | |
Persistent pseudocowpox virus infection of the skin of a foot in a cat. | |
Phylogenetic analysis of the large family of poxvirus ankyrin-repeat proteins reveals orthologue groups within and across chordopoxvirus genera | |
Poxvirus ankyrin repeat proteins are a unique class of F-box proteins that associate with cellular SCF1 ubiquitin ligase complexes | |
Poxvirus host range protein CP77 contains an F-box-like domain that is necessary to suppress NF-kappaB activation by tumor necrosis factor alpha but is independent of its host range function | |
Poxviruses | |
The reactivity of monoclonal antibodies against orf virus with other parapoxviruses and the identification of a 39 kDa immunodominant protein. | |
Recent isolates of parapoxvirus of Finnish reindeer (Rangifer tarandus tarandus) are closely related to bovine pseudocowpox virus | |
Recurrent localised cutaneous parapoxvirus infection in three cats | |
Resolution of cervical dysplasia is associated with T-cell proliferative responses to human papillomavirus type 16 E2. | |
Sequence and transcriptional analysis of a near-terminal region of the orf virus genome. | |
Short-term treatment of equine wounds with orf virus IL-10 and VEGF-E dampens inflammation and promotes repair processes without accelerating closure | |
Six widespread bacterial clones among Escherichia coli K1 isolates. | |
The structure and cloning of orf virus DNA. | |
The structure of a putative scaffolding protein of immature poxvirus particles as determined by electron microscopy suggests similarity with capsid proteins of large icosahedral DNA viruses | |
Structures of Orf Virus Chemokine Binding Protein in Complex with Host Chemokines Reveal Clues to Broad Binding Specificity | |
Therapeutic immunomodulation using a virus--the potential of inactivated orf virus. | |
Transcriptional repression of E-cadherin by human papillomavirus type 16 E6. | |
Vaccinia virus as a vaccine delivery system for marsupial wildlife | |
Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: intra-nasal vaccination | |
Viral vascular endothelial growth factor plays a critical role in orf virus infection. | |
Viral Vascular Endothelial Growth Factors Vary Extensively in Amino Acid Sequence, Receptor-binding Specificities, and the Ability to Induce Vascular Permeability yet Are Uniformly Active Mitogens |